Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Dumontet

Showing results (51-60 of 106) with videos related to

Pageof 11
Sort By:
Annals of the Rheumatic Diseases|May 26, 1999
Biopsy proven and biopsy negative temporal arteritis: differences in clinical spectrum at the onset of the disease. Groupe de Recherche sur l'Artérite à Cellules GéantesP Duhaut, L Pinède, H Bornet, et al.
Cell Motility and the Cytoskeleton|January 1, 1996
Differential expression of tubulin isotypes during the cell cycleC Dumontet, G E Durán, K A Steger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patientsY Bastion, C Sebban, F Berger, et al.
Bulletin Du Cancer|January 1, 1992
[Prognostic factors, late relapse and outcome of patients with aggressive malignant lymphoma: long term results of LNH-80 protocol]C Dumontet, Y Bastion, P Felman, et al.
Clinical Rheumatology|March 1, 1987
Synovial lipoma arborescens of the hipE R Noel, J G Tebib, C Dumontet, et al.
Bone Marrow Transplantation|July 22, 1999
Toxicities after peripheral blood progenitor cell transplantation for lymphoid malignancies: analysis of 300 cases in a single institutionN Ketterer, A Sonet, C Dumontet, et al.
Bone Marrow Transplantation|June 20, 2003
Autoimmune thrombocytopenic purpura after autologous stem cell transplantationO Hequet, G Salles, N Ketterer, et al.
British Journal of Cancer|July 2, 1998
Plasma levels of tumour necrosis factor and its soluble receptors correlate with clinical features and outcome of Hodgkin's disease patientsK Warzocha, J Bienvenu, P Ribeiro, et al.
Anticancer Research|June 9, 2001
Modulation of cancer cell multidrug resistance by an extract of Ficus citrifoliaP N Simon, A Chaboud, N Darbour, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patientsK Warzocha, G Salles, J Bienvenu, et al.
Pageof 11

Showing results (51-60 of 106) with videos related to

Sort By:
Pageof 11
Annals of the Rheumatic Diseases|May 26, 1999
Biopsy proven and biopsy negative temporal arteritis: differences in clinical spectrum at the onset of the disease. Groupe de Recherche sur l'Artérite à Cellules GéantesP Duhaut, L Pinède, H Bornet, et al.
Cell Motility and the Cytoskeleton|January 1, 1996
Differential expression of tubulin isotypes during the cell cycleC Dumontet, G E Durán, K A Steger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patientsY Bastion, C Sebban, F Berger, et al.
Bulletin Du Cancer|January 1, 1992
[Prognostic factors, late relapse and outcome of patients with aggressive malignant lymphoma: long term results of LNH-80 protocol]C Dumontet, Y Bastion, P Felman, et al.
Clinical Rheumatology|March 1, 1987
Synovial lipoma arborescens of the hipE R Noel, J G Tebib, C Dumontet, et al.
Bone Marrow Transplantation|July 22, 1999
Toxicities after peripheral blood progenitor cell transplantation for lymphoid malignancies: analysis of 300 cases in a single institutionN Ketterer, A Sonet, C Dumontet, et al.
Bone Marrow Transplantation|June 20, 2003
Autoimmune thrombocytopenic purpura after autologous stem cell transplantationO Hequet, G Salles, N Ketterer, et al.
British Journal of Cancer|July 2, 1998
Plasma levels of tumour necrosis factor and its soluble receptors correlate with clinical features and outcome of Hodgkin's disease patientsK Warzocha, J Bienvenu, P Ribeiro, et al.
Anticancer Research|June 9, 2001
Modulation of cancer cell multidrug resistance by an extract of Ficus citrifoliaP N Simon, A Chaboud, N Darbour, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patientsK Warzocha, G Salles, J Bienvenu, et al.
Pageof 11